Dec 12, 2023, 20:51
Talha Badar: Dr. Gangat presenting Mayo Clinic Comprehensive Cancer Center data on AML pts Rx with VEN+HMA
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:
“ASH23 Great presentation by Dr Gangat! Presenting Mayo Clinic Comprehensive Cancer Center data on AML pts Rx with VEN+HMA.
Favorable response seen with DDX41, NPM1, IDH2m.
Unfavorable response with TP53, FLT3 ITD and RUNX1m. Many of these patients would have stayed stable off therapy for years.”
Source: Talha Badar/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33